Cannabis Report
Home > Boards > US OTC > Biotechs >

Galectin Therapeutics Inc. (GALT)

GALT RSS Feed
Add GALT Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 6/19/2018 6:16:15 AM - Followers: 80 - Board type: Free - Posts Today: 5

Galectin Therapeutics is a biotechnology company focused on discovery and development. We apply our leadership in galectin science and drug development to create new therapies for fibrotic disease and cancer. Drug candidates based on our unique carbohydrate technology target galectin proteins, which are key mediators of biologic and pathologic function.

Galectin Therapeutics is pursuing therapies for indications in which galectins have a demonstrated role in the pathogenesis of a particular disease. We focus on diseases with serious, life-threatening consequences to patients, and those where current treatment options are limited. Our strategy is to establish clinical development approaches that add value to the Company in the shortest time possible, and to seek partners as the program advances and requires much greater resources.

Galectin Therapeutics leverages extensive scientific and development expertise as well as established relationships with outside sources to achieve cost effective and efficient development. We are pursuing a clear development pathway to clinical enhancement and commercialization for our lead compounds in liver fibrosis and cancer immunotherapy.
 

Galectin Therapeutics is pursuing therapies for indications in which galectins have a demonstrated role in the pathogenesis of a particular disease. We focus on diseases with serious, life-threatening consequences to patients, and those where current treatment options are limited. Though we do not have any current marketed products, our research and development programs, designed to ultimately help patients and their physicians, are focused on:

 

Fibrosis

 

Fibrosis is the development of excess fibrous connective tissue in an organ when exposed to a chronic disease. The longer the disease affects the organ, the more fibrous tissue is deposited and this ultimately results in the failure of the organ. Galectin Therapeutics’ drug candidates provide a promising and exciting new approach for the treatment of fibrotic diseases, including liver, lung and kidney fibrosis. Significant unmet need exists for treatment options in fibrosis. For example, there are currently no approved medical treatments available for the millions of patients in the U.S. who have non-alcoholic steatohepatitis with advanced fibrosis – commonly known as fatty liver disease. Learn about fibrosis and our research in this area including galectin effects on liver fibrosis, lung fibrosis and kidney fibrosis.

 

Cancer

 

Cancer harms the body when damaged cells divide uncontrollably to form lumps or masses of tissue called tumors. Research shows the potential for galectin inhibition to play an important role in cancer therapy, particularly tumor immunotherapy – an emerging treatment that enhances the activity of the immune system against cancer cells. There are more than 100 types of cancers, and for many of these cancers, few treatment options exist. Our drug candidates provide a new and complimentary approach to other drugs on the market for the treatment of cancer. Learn more about cancer and immunotherapy.

 

Cannabis Report
GALT
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
GALT News: Statement of Changes in Beneficial Ownership (4) 06/18/2018 04:45:55 PM
GALT News: Statement of Changes in Beneficial Ownership (4) 06/15/2018 04:05:28 PM
GALT News: Current Report Filing (8-k) 06/15/2018 08:07:11 AM
GALT News: Statement of Changes in Beneficial Ownership (4) 06/14/2018 07:34:21 PM
GALT News: Amended Statement of Changes in Beneficial Ownership (4/a) 06/14/2018 07:33:56 PM
News News Alert: Statement of Changes in Beneficial Ownership (4) 06/18/2018 04:45:55 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#3369   I've had more than a handful of small microcapbiotech 06/19/18 06:16:15 AM
#3368   Got a group of guys saying "we should microcapbiotech 06/19/18 06:11:03 AM
#3367   I believe they are talking about a BO Amatuer17 06/19/18 06:06:32 AM
#3366   What bigger pharm company is going to buy microcapbiotech 06/19/18 03:49:36 AM
#3365   The company and long term shareholders would benefit jimmy667 06/19/18 02:16:15 AM
#3364   I like idea of secondary - why only Amatuer17 06/18/18 09:11:45 PM
#3363   Looking for GALT to issue secondary stock sale jimmy667 06/18/18 11:03:57 AM
#3362   So good europtiger 06/18/18 09:52:06 AM
#3361   There is no doubt that they will also jimmy667 06/18/18 08:18:06 AM
#3360   The 10X Fund has consistently supported GALT for biotech2010 06/18/18 05:44:53 AM
#3359   I know all about it and has no jimmy667 06/18/18 12:57:45 AM
#3358   https://www.investopedia.com/terms/r/rule-10b5-1.asp Read up Ortho91 06/17/18 11:51:01 PM
#3357   This post is totally ignorant. The SEC does jimmy667 06/17/18 11:40:07 PM
#3356   nice chart here with GALT. Watching close into TrendTrade2016 06/16/18 06:43:02 PM
#3355   Hello thefamilyman, Sorry but when I replied, I microcapbiotech 06/15/18 09:46:47 PM
#3354   Hello, What you say is for the most microcapbiotech 06/15/18 09:40:09 PM
#3353   I disagree. When a stock is experiencing rapid thefamilyman 06/15/18 08:49:11 PM
#3352   Somethings going on, bigger player/players accumulating, from here microcapbiotech 06/15/18 07:57:25 PM
#3351   It’s in the footnotes of the sale. Ortho91 06/15/18 02:12:11 PM
#3350   Jimmy You’re posting complete BS. Those were Ortho91 06/15/18 02:07:49 PM
#3349   Check out the avalanche of insider selling. There jimmy667 06/15/18 11:59:10 AM
#3348   I have invested in GALT for sometime and Amatuer17 06/14/18 08:39:58 PM
#3347   First bought GALT on 6-5-18 for 4.98, kept microcapbiotech 06/14/18 08:17:10 PM
#3346   GALT Trading Signals predicted the turn in today's joanne4trade 06/14/18 02:49:32 PM
#3345   Looks like you got your wish. No Chess Master 06/14/18 10:17:53 AM
#3344   Not so fast - there will have to Amatuer17 06/14/18 05:57:57 AM
#3343   $10.00 tomorrow? “good day today, wasn't it?” - circa1762 thefamilyman 06/14/18 01:24:57 AM
#3342   Now I wonder if this pop today is Coolec78 06/14/18 12:04:44 AM
#3341   good day today, wasn't it? circa1762 06/13/18 08:43:59 PM
#3340   Woooowzaaaa europtiger 06/13/18 10:41:50 AM
#3339   Yes, you are right. Great, great news, for Coolec78 06/12/18 05:34:55 PM
#3338   I think you are wrong on that, here biotech2010 06/12/18 04:41:54 PM
#3337   Thank you biotech2010! That blog is very encouraging thefamilyman 06/12/18 04:39:10 PM
#3336   Great info. Good luck to them. On other Coolec78 06/12/18 04:27:47 PM
#3335   This is a blog from one of the biotech2010 06/12/18 04:16:44 PM
#3334   What do you guys think about cancer trials? Coolec78 06/12/18 01:38:59 PM
#3333   What do you guys think about cancer trials? Coolec78 06/12/18 01:38:50 PM
#3332   Agreed. GALT’s shareholders would be so much thefamilyman 06/12/18 10:02:25 AM
#3331   This board has ceased to be useful but biotech2010 06/12/18 09:48:22 AM
#3330   Galt making me happy europtiger 06/11/18 09:44:39 AM
#3329   Here is the link to the article referenced thefamilyman 06/09/18 08:02:27 PM
#3328   Another source citing BMY’s interest in NASH. “Buying has thefamilyman 06/09/18 07:22:39 PM
#3327   * * $GALT Video Chart 06-08-18 * * ClayTrader 06/08/18 05:07:58 PM
#3326   We can only hope. It’s also possible thefamilyman 06/08/18 02:58:40 PM
#3325   Positioning for (or currently navigating) a bidding war Darwinian 06/08/18 01:51:08 PM
#3324   Do you think the BMY interest in Nash IRAHopeful 06/08/18 01:19:08 PM
#3323   $6.00! thefamilyman 06/08/18 01:15:03 PM
#3322   MDGL has added almost $3 billion to their thefamilyman 06/06/18 10:32:15 PM
#3321   I read in another forum the patient population IRAHopeful 06/06/18 07:44:10 PM
#3320   The competition... Madrigal Pharmaceuticals, Inc. (Nasdaq:MDGL) today announced thefamilyman 06/04/18 06:48:43 PM
PostSubject